Gout is a condition that resulted from deposition of monosodium urate crystals in various tissues (eg joints, connective tissue, kidney).
The patient experiences acute and chronic arthritis, soft tissue inflammation, tophus formation, gouty nephropathy and nephrolithiasis.
Primary hyperuricemia occurs when uric acid saturation arises without coexisting diseases or drugs that alter uric acid production or excretion, while secondary hyperuricemia is a condition where excessive uric acid production or diminished renal clearance occurs as a result of a disease, drug, dietary product or toxin. 

Gout Drug Information

Drug Information

Indication: Symptomatic treatment of RA, periarthritis humelo-scapularis, peritendinitis, tendinitis, muscular pain, pain ...

Indication: Severe hypersensitivity & dermatological reaction; severe acute & chronic inflammatory & allergic ...

Indication: Pain & inflammation in rheumatic disease; exacerbation of OA & ankylosing spondylitis.

Indication: Pain relief eg, headache, migraine, dental, period, rheumatic & muscular pain & backache. Relieves fev...

Indication: Relief of fever, pain eg, dental pain & headache. Relief of muscle & joint inflammation.

Indication: Topical treatment of pain, inflammation & swelling eg, after sprains, contusions & strains. Supportive...

Indication: Inflammatory & degenerative, articular & extra-articular rheumatic disorders of muscles, joints, joint...

Indication: Symptomatic treatment of painful OA, RA & ankylosing spondylitis.

Indication: Ankylosing spondylitis, OA, RA & acute gout. Mild to moderate pain eg, migraine, primary dysmenorrhoea, ac...

Indication: Musculoskeletal & joint disorders eg, ankylosing spondylitis, OA & RA. Mild to moderate pain eg, dysme...

3  /  12
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
2 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 5 days ago
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).